ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

July 17-21, 2021. Philadelphia, PA.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z
  • Abstract Number: LPB0086

    GDP/GTP Exchange Factor MADD Drives Activation and Recruitment of Secretory Rab GTPases to Weibel-Palade Bodies

    M. Kat1, P. Bürgisser2, H. Janssen3, I. De Cuyper1, I. Conte4, A. Hume5, T. Carter4, J. Voorberg1, C. Margadant6, R. Bierings2

  • Abstract Number: PB1317

    Gender-specific Risk Prediction of Venous Thromboembolism for Patients Admitted to Intensive Care Units (ICU)

    I. Labbene1,2, N. Mezghani3, W. Sellami1,2, A. Ghorbel4, F. Kadri4, N. Nouri4, M. Ferjani1,2

  • Abstract Number: PB0038

    Generation of Anticoagulant RNA Aptamers Targeting Cofactors that Inhibit Clotting in Normal and COVID-19 Patient Samples

    H. Yu1, E. Soule1, L. Olson1, I. Naqvi1, S. Kumar2, S. Krishnaswamy2, B. Sullenger1

  • Abstract Number: PB0563

    Genetic and Clinical Determinants for the Outcome of Immune Tolerance Induction in Severe Hemophilia A – Preliminary Results

    A. Abdi1, I. Oomen1,2, S.Q. Nagelkerke3,4, K. Fischer5, M. Carcao6, G.E. Rivard7, N. Rydz8, J. Eikenboom9, A.B. Mohseny9, S. Schols10, F.W.G. Leebeek11, J. Geissler3, M.W. Tanck12, D. Lillicrap13, J. Voorberg2, T.W. Kuijpers3,4, K. Fijnvandraat1,2, S.C. Gouw1,14, International GO-ITI study group

  • Abstract Number: PB0618

    Genetic and Non-genetic Determinants for the Outcome of Immune Tolerance Induction in Patients with Hemophilia A and Inhibitors – A Systematic Review

    I. Oomen1,2, R. Mesquita Camelo3, S. Meireles Rezende3, J. Voorberg2, M.E. Mancuso4, J. Oldenburg5, M. Carcao6, D. Matino7, D. Lillicrap8, K. Fischer9, K. Fijnvandraat1,2, S.C. Gouw1,10, International GO-ITI study group

  • Abstract Number: PB0964

    Genetic and Non-genetic Regulators of Platelet Function in Healthy Tanzanian Individuals

    V. Kullaya1, G. Temba2, N. Fadaq3, C. Boahen3, T. Pecht4, M. Netea3, B. Mmbaga1, A. van der Ven3, Q. de Mast3

  • Abstract Number: LPB0032

    Genetic Characterization of von Willebrand Disease Type 2 in Milan Cohort Patients

    O. Seidizadeh1, L. Baronciani1, M.T. Pagliari1, G. Cozzi1, P. Colpani1, S.M. Siboni1, E. Biguzzi1, F. Peyvandi1,2

  • Abstract Number: OC 22.1

    Genetic Truncation of the Fibrinogen αC-region in Mice Results in Severe Hypofibrinogenemia with Preservation of Hemostasis and Protection from Venous Thrombosis

    W.S. Hur1,2,3, E.G Bouck1,3, D.S Paul3,4, O. Negron3,2,1, L.G Poole5, H. Cline-Fedewa5, E. Clark4, T. Ugarova6, A.S Wolberg1,3, W. Bergmeier3,4, J.P Luyendyk5, M.J Flick1,2,3

  • Abstract Number: OC 39.4

    Genome Wide Association Analysis of Neutrophils Extracellular Traps

    G. Munsch1, D. Aïssi1, C. James2,3, H. Jacqmin-Gadda1, P.-E. Morange4,5, J.-F. Deleuze6,7, D.-A. Trégouët1, D. Smadja8,9

  • Abstract Number: PB0134

    Genome-wide Knockdown of Chromatin Binding and Regulatory Protein Genes and Regulation of Zebrafish tfpia Gene Expression

    R. Raman1, W. Fallatah1, A. Al Qaryoute1, P. Jagadeeswaran1

  • Abstract Number: PB0466

    GEPHARD – The PUP Cohort of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research´ – A Progress Report

    C. Bildingmaier1, M. Olivieri1, M. Türknetz2, S. Schultze-Strasser2, C. Escuriola Ettingshausen3, K. Kentouche4, B. Zieger5, K. Kurnik1, W. Eberl6, C. Königs2, GEPHARD study group

  • Abstract Number: PB0689

    GGCX Mutations Lead to Different γ-carboxylation Status of Vitamin K Dependent Coagulation Proteins

    S. Ghosh1, J. Mueller1, A. Biswas1, K. Höning2, V. Hornung3, F. Forin1, M. Watzka1, k. J. Czogalla1, J. Oldenburg1

  • Abstract Number: PB0278

    Glenzocimab, a Novel Antiplatelet Therapy in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS): The GARDEN Study, a Phase 2 Clinical Trial

    A. Comenducci1, S. Lebel-Binay1, G. Avenard1, J. Pottecher2, V. Sato3, M. Jandrot-Perrus4, Y. Plétan1

  • Abstract Number: PB0090

    Global Coagulation Assay in a Patient Affected by AL Amyloidosis

    S. Arcudi1, A. Artoni2, E. Scalambrino2, M. Clerici2, F. Valsecchi3, M. Capecchi4, A. Tripodi2, F. Peyvandi1,2

  • Abstract Number: PB1045

    Global Coagulation Assays and Endothelial Biomarkers in Patients with Diabetes Mellitus

    H.Y. Lim1,2,3, B. Lui2, M. Tacey2, A. Kwok2, S. Varadarajan2, M. Sashindranath3, C. Selan3, G. Donnan1, H. Nandurkar3, P. Ho2,1

  • Abstract Number: PB1042

    Global Coagulation Assays in Chronic Kidney Disease

    B. Lui1, D. Barit1, M. Sashindranath2, C. Selan2, G. Donnan3, H. Nandurkar2, P. Ho1, H.Y. Lim2,1,3

  • Abstract Number: PB0244

    Global Haemostatic Tests Demonstrate the Absence of Hypercoagulability in Non-supplemental Oxygen Dependent COVID-19 Patients

    B.E. Fan1,2,3,4, C.L.L. Sum5, R.M. Lee6,3,4, J.Y. Lim6,3,4, C.F. Bok7,8, B.E. Young7,8,3,4, C.B. Lye7,8,3,4, Y.W. Chia9,3,3,4, K.H. Ong1,2,3,4

  • Abstract Number: PB0668

    Global Octim® Shortage: Experience in Strasbourg

    J. Wimmer1, A.-C. Gerout2, L. Sattler1, L. Grunebaum1, O. Feugeas3, D. Desprez3

  • Abstract Number: LPB0022

    Global Seroprevalence of Pre-existing Immunity against AAV Serotypes in People with Hemophilia A

    R. Klamroth1, G. Hayes2, T. Andreeva3, T. Suzuki4, B. Hardesty5, M. Shima6, T. Pollock7, P. Slev7, J. Oldenburg8, M.C Ozelo9, S.-M. Castet10, J. Mahlangu11, F. Peyvandi12, R. Kazmi13, A.D Leavitt14, M. Callaghan15, B. Pan-Petesch16, D. Quon17, M. Li2, W.Y. Wong2

  • Abstract Number: LPB0014

    Global Thrombosis Test: Occlusion by Coagulation or SIPA?

    V. Clavería1, P. Yang1, M. Griffin1, D. Ku1

  • Abstract Number: LPB0084

    GPVI, a New Binding Partner for pro-coagulant Factor VIII on Platelets

    R. Sekar1, V. Proulle1,2, S. Loyau3, Y. Boulaftali3, A. Mimoun1, M. Jandrot-Perrus3, S. Lacroix-Desmazes1

  • Abstract Number: OC 02.1

    Granulocyte Microvesicles with a High Plasmin Generation Capacity Promote Clot Lysis and Improve Outcome in Septic Shock

    S. Cointe1,2, L. Vallier2, A. Bonifay2, K. Harti3, M. Dacos2, N. Macagno4, C. Judicone5, C. Chareyre2, D. Frankel6, s. Robert2, S. Hraiech7, M.-C. Alessi8, J. Albanese3, f. Dignat-George2,1, R. Lacroix2,1

  • Abstract Number: OC 46.3

    Growth Differentiation Factor-15 for Prediction of Bleeding in Cancer Patients

    F. Mulder1, F. Bosch2, N. van Es2, P.W. Kamphuisen2, S. Middeldorp3, R. Mallick4, M. Carrier4, P. Wells4

  • Abstract Number: OC 36.1

    Growth Differentiation Factor-15 Predicts Major Bleeding, Cardiovascular Events, and All-cause Mortality in Patients with End-stage Renal Disease on Hemodialysis

    S. Nopp1, O. Königsbrügge1, I. Pabinger1, C. Ay1

Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley